American International Group, Inc. Harrow Health, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$9.3 - $13.23 $1,190 - $1,693	-128 Reduced 0.85%	14,939 $197,000
Q4 2023 Feb 13, 2024	BUY	$8.1 - $16.36 $3,588 - $7,247	443 Added 3.03%	15,067 $168,000
Q3 2023 Nov 13, 2023	BUY	$14.03 - $22.08 $29,575 - $46,544	2,108 Added 16.84%	14,624 $210,000
Q2 2023 Aug 04, 2023	BUY	$17.37 - $28.08 $217,402 - $351,449	12,516 New	12,516 $238,000
Q2 2021 Aug 13, 2021	SELL	$6.68 - $11.07 $87,133 - $144,397	-13,044 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$6.26 - $11.03 $212 - $375	34 Added 0.26%	13,044 $88,000
Q4 2020 Feb 12, 2021	SELL	$4.76 - $6.93 $1,775 - $2,584	-373 Reduced 2.79%	13,010 $89,000
Q3 2020 Nov 04, 2020	SELL	$4.71 - $7.36 $1,431 - $2,237	-304 Reduced 2.22%	13,383 $75,000
Q2 2020 Aug 12, 2020	BUY	$3.61 - $6.47 $49,410 - $88,554	13,687 New	13,687 $71,000

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.